Website được thiết kế tối ưu cho thành viên chính thức. Hãy Đăng nhập hoặc Đăng ký để truy cập đầy đủ nội dung và chức năng. Nội dung bạn cần không thấy trên website, có thể do bạn chưa đăng nhập. Nếu là thành viên của website, bạn cũng có thể yêu cầu trong nhóm Zalo "NCKH Members" các nội dung bạn quan tâm.

Rối loạn phát triển giới tính do đột biến gen 3beta-Hydroxysteroid Dehydrogenase Typ II

nckh
Thông tin nghiên cứu
Loại tài liệu
Bài báo trên tạp chí khoa học (Journal Article)
Tiêu đề
Rối loạn phát triển giới tính do đột biến gen 3beta-Hydroxysteroid Dehydrogenase Typ II
Tác giả
Vũ Chí Dũng; Nguyễn Thị Hoàn; Nguyễn Thanh Liêm; Bùi Phương Thảo; Nguyễn Ngọc Khánh; Cấn Thị Bích Ngọc; Lê Anh Dũng; Yves Morel
Năm xuất bản
2012
Số tạp chí
DB
Trang bắt đầu
296-303
ISSN
1859-1868
Abstract

3beta-Hydroxysteroid dehydrogenase (3beta-HSD) deficiency is a cause of 46,XY disorder of sex development (DSD) and is a rare cause of CAH caused by inactivating mutations in the HSD382 gene. Objectives: To describe phenotype and to identify mutations of HSD382 in two classic beta-HSD deficient patients belonging to two apparently unrelated pedigrees. Methods: This is a case series study. Family history and clinical manifestations were described. Genomic DNA from these patients was extracted using standard procedures from the peripheral blooclleukocytes. Mutation analysis of b HSD382 was performed using Polymerase chain reaction (PCR) and DNA direct sequencing. Results: The 46,XY newborn referred at 2.5th month of life with salt loss associated with hyponatremia (123 nmol/L) and hyperpigmentation. The testes were palpable in the scrotum but associated with a severe a hypospadias (micropenis 0.5 cm; posterior). At 4 months of age, a second adrenal crisis has occurred with hyponatremia 127 nmol/L and increased 170H-Progesterone (3400 ng/dl) in this 46,XY DSD. This clinical and biological data associated with a sibling with female phenotype deceased at 18 months old after adrenal crisis (1st occurred at 7 days of life) suggest the diagnosis of 3beta-HSD deficiency. The sequencing of HSD382 confirms the diagnosis because he is homozygous for a missense mutation, pAla161Pro. This mutation affects an aminoacid conserved in all species and is located in one two ahelix involved in the dimerization of the two sub-units of the enzyme. The changing from Alanine to Proline could break the alpha-helix. The same mutation has been found in the other family. The 46,XY newborn referred at 3th month of life with severe dehydration associated with hyponatremia (93 nmol/L) and hyperpigmentation. The testes were palpable in the scrotum but associated with a severe hypospadias (micropenis 0.5 cm; posterior). Clinical presentation and increased 170H-Progesterone (970 ng/dl) in this 46, XY DSD suggest the diagnosis of 3beta-HSD deficiency. The sequencing of HSD382 also confirms the diagnosis because he is homozygous for a missense mutation, pAla161Pro. The severity of this mutation correlates well with the phenotype in these patients. Parents of two unrelated pedigrees are not consanguinity. Conclusions: This study contributes to a better understanding of the molecular defects of 3beta-HSD and of the phenotypic heterogeneity of DSD and CAH related to 3beta-HSD deficiency.